Study of Cryotherapy for Renal Tumors

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 2009 by National Taiwan University Hospital.
Recruitment status was Recruiting

Sponsor:

Information provided by:

National Taiwan University Hospital

ClinicalTrials.gov Identifier:

NCT00858975

First received: March 9, 2009

Last updated: NA

Last verified: February 2009

History: No changes posted

Purpose

The purpose of this study is to study the change of tumor size and serum cytokine in the patients who received cryotherapy for the renal tumors.

Condition	Intervention
Renal Tumors	Procedure: cryotherapy

Study Type:	Interventional
Study Design:	Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Study of Cryotherapy for Renal Tumors

Resource links provided by NLM:

MedlinePlus related topics: Cancer Kidney Cancer

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:

Tumor size [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Estimated Enrollment:	90
Study Start Date:	October 2007
Estimated Study Completion Date:	October 2010
Estimated Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Cryotherapy The patients who receive cryotherapy for their renal tumors	Procedure: cryotherapy Placing 4-6 cryotherapy probes into the renal tumors and conducting two cycles of freezing and thawing

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

The patients who have renal tumor less than 7 cm and receive cryotherapy

Exclusion Criteria:

The tumor size is larger than 7 cm
The patients do not approve the surgery

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00858975

Contacts

Contact: Yeong-Shiau Pu, Ph.D.

886-2-23123456 ext 65249

yspu@ntu.edu.tw

Locations

Taiwan
National Taiwan University Hospital	Recruiting
Taipei, Taiwan, 100
Contact: Yeong-Shiau Pu, Ph.D. 886-2-23123456 ext 65249 yspu@ntu.edu.tw

Sponsors and Collaborators

National Taiwan University Hospital

More Information

No publications provided

Responsible Party:	Yeong-Shiau Pu, Department of Urology / National Taiwan University Hospital
ClinicalTrials.gov Identifier:	NCT00858975 History of Changes
Other Study ID Numbers:	200709063R
Study First Received:	March 9, 2009
Last Updated:	March 9, 2009
Health Authority:	Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:

renal tumor
cryotherapy
cytokine

Additional relevant MeSH terms:

Kidney Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site

Neoplasms
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on May 19, 2013

To Top